Device Trial Radar · NCT06394739
RevCore for In Stent Thrombosis
Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
100
Planned (sponsor's estimate)
Start
Sep 9, 2024
Primary completion
Apr 2027
Study completion Apr 2028
Sponsor
- Lead sponsor
- Inari MedicalNot on our public-company list
- Sponsor type
- Industry
- First posted
- May 1, 2024
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this research is to collect information about how the RevCore Thrombectomy Catheter works to treat stent blockages.
Conditions
- In-stent Thrombosis
Interventions
ThrombectomyDevice
RevCore Thrombectomy to treat in-stent thrombosis
Primary outcomes
What the sponsor says the trial is designed to measure.
- Evidence of successful stent recanalizationTime frame: Immediately after the RevCore thrombectomy procedure for in-stent thrombosis
Locations
17 sites in 1 country. Site status is shown where the registry gives one.
Yale University
New Haven, Connecticut · Recruiting
16 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.